Centogene and the MJFF are teaming up to investigate genetic risk factors for Parkinson’s disease, with a focus on mutations in the GBA gene.

michaelxfoxxy

#grapes#wine#rural#Italianwine#Italy#frapeyard

Olatec Therapeutics has been awarded a MJFF grant to further investigate its lead oral candidate, dapansutrile, in Parkinson's mouse models.